Method of treatment of age-related macular degeneration (amd)

Abstract

The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or otherwise treating or ameliorating the symptoms of, age-related macular degeneration (AMD) or related retinal conditions in mammals and in particular humans. The present invention further provides therapeutic compositions enabling dose-dependent or dose-specific administration of agents useful in the treatment and prophylaxis of age-related macular degeneration or related retinal degenerative conditions.

1 .- 19 . (canceled) 
     
     
         20 . A compound selected from the following: 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         21 . The compound of  claim 20  which is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         22 . The compound of  claim 21  which is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         23 . The compound of  claim 20  which is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         24 . A pharmaceutical composition comprising a compound of  claim 20  or a pharmaceutically acceptable salt thereof and a pharmaceutical carrier therefor. 
     
     
         25 . The pharmaceutical composition according to  claim 24  where the compound is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         26 . The pharmaceutical composition according to  claim 24  where the compound is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         27 . The pharmaceutical composition according to  claim 23  where the compound is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof.